Rafaël Fonseca
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments 313
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 73
- Myeloproliferative Neoplasms: Diagnosis and Treatment 28
- Oncology top 0.1%
- Cancer Treatment and Pharmacology 70
- Peptidase Inhibition and Analysis 46
- Molecular Biology top 0.1%
- Protein Degradation and Inhibitors 143
- Amyloidosis: Diagnosis, Treatment, Outcomes 46
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment 40
- Co-authors
- S. Vincent RajkumarPhilip R. GreippAngela DispenzieriRobert A. KyleMorie A. GertzMartha Q. LacyThomas E. WitzigJohn A. Lust
- Cited by
- HematologyGeneticsOncology
- Journals
- New England Journal of Medicine (1 paper)The Lancet (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Rafaël Fonseca
418 papers receiving 25.2k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Hematology 17.5k
- Genetics 5.8k
- Oncology 9.9k
- Molecular Biology 16.2k
- Pathology and Forensic Medicine 3.7k
Countries citing papers authored by Rafaël Fonseca
This map shows the geographic impact of Rafaël Fonseca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafaël Fonseca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafaël Fonseca more than expected).
Fields of papers citing papers by Rafaël Fonseca
This network shows the impact of papers produced by Rafaël Fonseca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafaël Fonseca. The network helps show where Rafaël Fonseca may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rafaël Fonseca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 12 | |
| 5 | 2024 | 10 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 13 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 13 | |
| 12 | 2018 | 24 | |
| 13 | 2015 | 150 | |
| 14 | Clonal competition with alternating dominance in multiple myelomabreakdown → | 2012 | 456 |
| 15 | 2012 | 269 | |
| 16 | 2010 | 42 | |
| 17 | 2009 | 226 | |
| 18 | 2007 | 285 | |
| 19 | 2007 | 195 | |
| 20 | 2000 | 1 |
About Rafaël Fonseca
Rafaël Fonseca is a scholar working on Hematology, Genetics and Oncology, having authored 441 papers that have together received 25.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (313 papers), Protein Degradation and Inhibitors (143 papers), Chronic Lymphocytic Leukemia Research (73 papers), Cancer Treatment and Pharmacology (70 papers), Peptidase Inhibition and Analysis (46 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (46 papers), Lymphoma Diagnosis and Treatment (40 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers). The work is most often cited by research in Hematology (17.5k citations), Genetics (5.8k citations) and Oncology (9.9k citations). Rafaël Fonseca has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include S. Vincent Rajkumar, Philip R. Greipp, Angela Dispenzieri, Robert A. Kyle, Morie A. Gertz, Martha Q. Lacy, Thomas E. Witzig, John A. Lust, Shaji Kumar and A. Keith Stewart. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.